Improvement of the experimental setup to assess cutaneous bioavailability on human skin models: Dynamic protocol

Skin Pharmacology and Applied Skin Physiology

Volumn 15, Issue SUPPL. 1, 2002, Pages 31-39

  Dreher, F ^a   Patouillet, C ^a   Fouchard, F ^a   Zanini, M ^a   Messager, A ^a   Roguet, R ^a   Cottin, M ^a   Leclaire, J ^a   Benech Kieffer, F ^a  

^a L ORÉAL RECHERCHE   (France)

Author keywords

Benzoic acid; Caffeine; Dynamic diffusion cell; EpiDerm ; Episkin ; Human skin model; Mannitol; Percutaneous absorption

Indexed keywords

RECEPTOR; MANNITOL;

ACCURACY; ARTICLE; BIOAVAILABILITY; BIOLOGICAL MODEL; CONTROLLED STUDY; DIFFUSION; EPIDERMIS; EXCISION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; LIQUID; MORPHOLOGY; PRIORITY JOURNAL; SAMPLING; SKIN ABSORPTION; SKIN SURFACE; ARTIFICIAL SKIN; DIFFUSION CHAMBER; DRUG EFFECT; DRUG SCREENING; METABOLISM; METHODOLOGY; PHYSIOLOGY; SKIN; STANDARD;

BIOLOGICAL AVAILABILITY; DIFFUSION CHAMBERS, CULTURE; DRUG EVALUATION, PRECLINICAL; HUMANS; MANNITOL; SKIN; SKIN ABSORPTION; SKIN, ARTIFICIAL;

EID: 0036460002     PISSN: 14222868     EISSN: None     Source Type: Journal    
DOI: 10.1159/000066683     Document Type: Article

References (18)

1. Bronaugh RL: Methods for in vitro percutaneous absorption. Toxicol Methods 1995;5:265-273.
2. Howes D, Guy R, Hadgraft J, Heylings J, Hoeck U, Kemper F, Maibach H, Marty JP, Merk H, Parra J, Rekkas D, Rondelli I, Schaefer H, Täuber U, Verbiese N: Methods for assessing percutaneous absorption. The report and recommendations of ECVAM workshop 13. ATLA 1996;24:81-106.
3. Diembeck W, Beck H, Benech-Kieffer F, Courtellemont P, Dupuis J, Lovell W, Paye M, Spengler J, Steiling W: Test guidelines for in vitro assessment of dermal absorption and percutaneous penetration of cosmetic ingredients. Food Chem Toxicol 1999;37:191-205.
4. Ernesti AM, Swiderek M, Gay R: Absorption and metabolism of topically applied testosterone in an organotypic skin culture. Skin Pharmacol 1992;5:146-153.
5. Régnier M, Caron D, Reichert U, Schaefer H: Barrier function of human skin and human reconstructed epidermis. J Pharm Sci 1993;82:404-407.
6. Roguet R, Régnier M, Cohen C, Dossou KG, Rougier A: The use of in vitro reconstituted human skin in dermotoxicity testing. Toxicol In Vitro 1994;8:635-639.
7. Robert M, Dusser I, Muriel MP, Noël-Hudson MS, Aubery M, Wepierre J: Barrier function of reconstructed epidermis at the air-liquid interface: Influence of dermal cells and extracellular components. Skin Pharmacol 1997;10:247-260.
8. Doucet O, Garcia N, Zastrow L: Skin culture model: A possible alternative to the use of excised human skin for assessing in vitro percutaneous absorption. Toxicol In Vitro 1998;12:423-430.
9. Ponec M, Wauben-Penris PJJ, Burger A, Kempenaar J, Boddé HE: Nitroglycerin and sucrose permeability as quality markers for reconstructed human epidermis. Skin Pharmacol 1990;3:126-135.
10. Régnier M, Caron D, Reichert U, Schaefer H: Reconstructed human epidermis: A model to study in vitro the barrier function of the skin. Skin Pharmacol 1992;5:49-56.
11. Yang JJ, Krueger AJ: Evaluation of two commercial human skin cultures for in vitro percutaneous absorption. In Vitro Toxicol 1992;5:211-217.
12. Michel M, Germain L, Bélanger PM, Auger FA: Functional evaluation of anchored skin equivalent cultured in vitro: Percutaneous absorption studies and lipid analysis. Pharm Res 1995;12:455-458.
13. Fares HM, Chatterjee S, Hayward M: In vitro permeation and irritation of benzoyl peroxide-containing products. Int J Pharm 1996;133:215-222.
14. Gysler A, Kleuser B, Sippl W, Lange K, Korting HC, Höltje HD, Schäfer-Korting M: Skin penetration and metabolism of topical glucocorticoids in reconstructed epidermis and in excised human skin. Pharm Res 1999;16:1386-1391.
15. Squier CA, Kremer M, Wertz PW: Continuous flow mucosal cells for measuring the in-vitro permeability of small tissue samples. J Pharm Sci 1997;86:82-84.
16. Roguet R, Cohen C, Dossou KG, Rougier A: Episkin, a reconstituted human epidermis for assessing in vitro the irritancy of topically applied compounds. Toxicol in Vitro 1994;8:283-291.
17. Roguet R, Beck H, Boelsma E, Bracher M, Faller C, Harris I, Lotte C, Dreher F, Ponec M: Testing and improvement of reconstructed skin kits in order to elaborate European standards: First results (poster presentation). 3rd Congress on Alternatives and Animal Use in Life Sciences, Bologna 1999.
18. Lotte C, Patouillet C, Zanini M, Messager A, Roguet R: Permeation and skin absorption: Reproducibility of various industrial reconstructed human skin models. Skin Pharmacol Appl Skin Physiol 2002;15(suppl 1):18-30.